Atlas Trials

Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01)

Clinical trial NCT01329640 · TERMINATED

Trial details

NCT number
NCT01329640
Sponsor
Instituto do Cancer do Estado de São Paulo
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced HER2-positive Breast Cancer
Start date
2010-09-01
Primary completion
2011-09-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.